3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Uveal Melanoma
1
Retinal Diseases
1
Melanoma
1
Macular Degeneration
1
Choroid Diseases
1
Interventions
salicylhydroxamic acid
1
Triamcinolone Acetonide
1
Ranibizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Choroid Diseases
×
Triamcinolone Acetonide
×
Clear all
NCT00811200
2009-07-02
TORR
Leiden University Medical Center
Phase 2/3
Unknown
220 enrolled